Predictive models of tumour response to treatment using functional imaging techniques by Marcu, L. et al.




Loredana G. Marcu, Eva Bezak, Iuliana Toma-Dasu, and Alexandru Dasu 
Predictive models of tumour response to treatment using functional imaging techniques 
Computational and Mathematical Methods in Medicine, 2015; 2015:571371-1-571371-2 
Copyright © 2015 Loredana G. Marcu et al. This is an open access article distributed under the 
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 






























Predictive Models of Tumour Response to Treatment Using
Functional Imaging Techniques
Loredana G. Marcu,1,2 Eva Bezak,2,3 Iuliana Toma-Dasu,4 and Alexandru Dasu5
1Faculty of Science, University of Oradea, 410087 Oradea, Romania
2School of Chemistry & Physics, University of Adelaide, Adelaide, SA 5000, Australia
3Department of Physics, Royal Adelaide Hospital, Adelaide, SA 5000, Australia
4Medical Radiation Physics Division, Stockholm University and Karolinska Institutet, 171 76 Stockholm, Sweden
5Department of Medical and Health Sciences, Radiation Physics, Linko¨ping University, 581 85 Linko¨ping, Sweden
Correspondence should be addressed to Loredana G. Marcu; loredana@marcunet.com
Received 14 December 2014; Accepted 14 December 2014
Copyright © 2015 Loredana G. Marcu et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The aim of the current special issue was to bring together
articles on various aspects of tumour modelling focusing on
treatment response and prediction of clinical outcome based
on functional imaging techniques.
Together with technological and radiobiological advan-
ces, tumourmodelling is an emerging area of oncology, which
plays a key role in predicting treatment outcome in cancer
patients. Despite the complexity of tumour biology and its
microenvironment, computational andmathematicalmodels
of virtual cancer behaviour and response to treatment are
successfully developed and employed for clinical research. A
mathematical (delay differential) model with optimal control
for tumour-immune response with chemoimmunotherapy
is presented by F. A. Rihan et al. in their research paper
that describes the interaction of tumour cells and immune
response cells with external therapy. In their model, the
authors propose a numerical technique to solve the optimal
control problem and identify the best strategy to combine
chemotherapy and immunotherapy in order to minimise
tumour load while maximising the strength of the immune
system.
Current diagnostic and imaging methods provide in-
depth metabolic information that can be employed for
tumour modelling. Latest technical and molecular advances
in the field of nuclear medicine offer new possibilities
in functional imaging, overcoming some of the confines
imposed by previous diagnostic techniques. Positron emis-
sion tomography (PET) is the most advanced technology
designed to provide metabolic information of disease, treat-
ment monitoring, and also evaluation of treatment outcome.
Together with other quantitative imaging techniques, such
as dynamic contrast-enhanced MRI, PET is a promising
diagnostic tool assisting in patient stratification for specific
therapies, evaluation of drug efficacy, assessment of chemo-
and radiotherapy outcome, and prediction of survival.
This research idea is underlined in the paper by M.
Jennings et al., which focuses on PET-specific parameters
and radiotracers in theoretical tumour modelling. The work
reviews the use of PET/CT information applied to in silico
models of tumour growth, development, and behaviour
during treatment. Tumour-related parameters such as cell
proliferation, hypoxia, angiogenesis, and pH as well as
PET/CT-specific biophysical parameters by means of SUV
(standardized uptake value) and Hounsfield units are revis-
ited in the context of computational modelling of complex
processed involving tumour kinetics and treatment outcome.
While several PET radiotracers have been developed
for clinical use to target specific tumour properties, FDG
(fluorodeoxyglucose) continues to be the most commonly
used radionuclide in functional imaging as it offers unique
information for tumour detection, staging, target definition,
and response monitoring during radio- and chemotherapy.
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In this special issue, J. Jeong and J. O. Deasy have modelled
the relationship between FGD uptake and tumour radiore-
sistance as a function of the tumour microenvironment.
The mechanistic model has considered cellular status to be
dictated by glucose and oxygen content, showing that cells
in the intermediate stress state (that receive glucose but not
oxygen) present an increased avidity of FDGwhen compared
to well-oxygenated cells. The role of hypoxia and the current
status of hypoxia imaging including PET-specific markers
are discussed by L. G. Marcu et al. in their review paper
written in the context of head and neck cancer. Hypoxia-
specific PET markers have been implemented in several
clinical trials to quantify hypoxic tumour subvolumes for
dose painting and personalised treatment planning. Tracer
pharmacokinetics and PET-derived functional parameters
serve as important input data for in silicomodels that aim to
simulate or interpret the acquired image.The paper discusses
two main streams of PET tracer modelling: (1) models of
specific tracer/oxygen dynamics with the aim of simulating
PET images leading to results that are in close agreement
with real PET images and (2) utilisation of PET data within
a separate tumour model with the aim of creating a more
specific model that is predictive of response to treatment.
The authors have collated analytical compartment models
of tracer pharmacokinetics, stochastic models of treatment
response using probability distribution functions, and reports
on model predictions within clinical radiotherapy planning
systems of dose distribution. A pertinent conclusion of
the review is that the role of computer models based on
functional imaging techniques in understanding patient-
specific tumour behaviour is effusively justified.
The challenge of hypoxia in cancermanagement is further
analysed by M. M. Iglesias et al. in a research article looking
at the multimodality functional imaging in radiotherapy
planning and the relationship between dynamic contrast-
enhanced (DCE) MRI, diffusion-weighted MRI, and FDG-
PET in order to develop predictive individualised models of
tumour response to radiotherapy in head and neck cancer
patients. For an optimal biologically guided radiotherapy,
to obtain relevant datasets on tumour hypoxia and cellular
density, there is a need to understand the correlations and
interactions between various functional imaging modalities.
Parameters such as SUV (PET), Hounsfield units, dose, ADC
(apparent diffusion coefficient) maps (MRI), and contrast
exchange coefficients (DCE-MRI) have been recorded for
each patient from the study and the relationship between
parameters analysed. The authors concluded that the above
functional parameters based on different image datasets
are valuable in describing in a complex manner tumour
oxygenation and vascularisation, cell density, and tumour
malignity offering, therefore, treatment personalisation and
optimisation.
A central motif of today’s cancer management is per-
sonalised treatment planning and delivery. While this trend
is featured in all papers of the current special issue, a
more focused view upon treatment individualisation via
multidimensional radiotherapy is presented in the work of I.
Toma-Dasu and A. Dasu. According to the authors, the key
approach tomaximise the individualisation of treatment is by
combining multiparameter information from imaging with
predictive information from biopsies and molecular analyses
and also by monitoring tumour response to treatment. The
emphasis of the paper is on biologically adapted radiation
therapy (BIOART), which is based on both pretreatment con-
ditions and intrinsic responsiveness assessed using functional
imaging techniques. The authors suggest that the BIOART
concept should replace the simple dose painting approach
for amore optimalmanagement of radioresistant subvolumes
within the BTV (biological target volume). Functional imag-
ing is shown to have the potential to provide a paradigm shift
in treatment planning and optimisation that extends beyond
target definition.
In silico modelling in cancer research was and continues
to be a very important tool of treatment simulation and
optimisation, contributing to a more personalised medicine
for an improved patient outcome. The use of computational
models for treatment assessment and outcome prediction is
fast growing and the power of in silico models as preclinical
tools becomes acknowledged. Therefore, multidisciplinary
research leading to predictive models of tumour response to
treatment using functional imaging techniques needs to be
encouraged to enable further developments in the diagnostic
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